Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 384

1.

d-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin in humans.

Benso A, Prodam F, Lucatello B, Gramaglia E, Riganti F, Schneider H, van der Lely AJ, Muccioli G, Ghigo E, Broglio F.

Neuropeptides. 2007 Feb;41(1):45-9. Epub 2006 Nov 16.

PMID:
17112585
2.

Cortistatin-8, a synthetic cortistatin-derived ghrelin receptor ligand, does not modify the endocrine responses to acylated ghrelin or hexarelin in humans.

Prodam F, Benso A, Gramaglia E, Lucatello B, Riganti F, van der Lely AJ, Deghenghi R, Muccioli G, Ghigo E, Broglio F.

Neuropeptides. 2008 Feb;42(1):89-93. Epub 2007 Dec 3.

PMID:
18061663
3.

Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans.

Broglio F, Gottero C, Benso A, Prodam F, Casanueva FF, Dieguez C, van der Lely AJ, Deghenghi R, Arvat E, Ghigo E.

Clin Endocrinol (Oxf). 2003 Jan;58(1):92-8.

PMID:
12519418
4.

Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.

Arvat E, Maccario M, Di Vito L, Broglio F, Benso A, Gottero C, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Camanni F, Ghigo E.

J Clin Endocrinol Metab. 2001 Mar;86(3):1169-74.

PMID:
11238504
5.

Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans.

Broglio F, Gottero C, Prodam F, Gauna C, Muccioli G, Papotti M, Abribat T, Van Der Lely AJ, Ghigo E.

J Clin Endocrinol Metab. 2004 Jun;89(6):3062-5.

PMID:
15181099
6.

The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state.

Broglio F, Gianotti L, Destefanis S, Fassino S, Abbate Daga G, Mondelli V, Lanfranco F, Gottero C, Gauna C, Hofland L, Van der Lely AJ, Ghigo E.

Clin Endocrinol (Oxf). 2004 May;60(5):592-9.

PMID:
15104562
7.

The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans.

Di Vito L, Broglio F, Benso A, Gottero C, Prodam F, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Ghigo E, Arvat E.

Clin Endocrinol (Oxf). 2002 May;56(5):643-8.

PMID:
12030916
8.

Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH.

Arvat E, di Vito L, Maccagno B, Broglio F, Boghen MF, Deghenghi R, Camanni F, Ghigo E.

Peptides. 1997;18(6):885-91.

PMID:
9285939
9.

Endocrine responses to ghrelin in adult patients with isolated childhood-onset growth hormone deficiency.

Aimaretti G, Baffoni C, Broglio F, Janssen JA, Corneli G, Deghenghi R, van der Lely AJ, Ghigo E, Arvat E.

Clin Endocrinol (Oxf). 2002 Jun;56(6):765-71.

PMID:
12072046
10.

Cortistatin-17 and -14 exert the same endocrine activities as somatostatin in humans.

Gottero C, Prodam F, Destefanis S, Benso A, Gauna C, Me E, Filtri L, Riganti F, Van Der Lely AJ, Ghigo E, Broglio F.

Growth Horm IGF Res. 2004 Oct;14(5):382-7.

PMID:
15336231
11.

Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans.

Arvat E, Di Vito L, Lanfranco F, Broglio F, Giordano R, Benso A, Muccioli GP, Deghenghi R, Ghigo E.

J Endocrinol Invest. 1999 Feb;22(2):91-7.

PMID:
10195374
12.

Interaction of the growth hormone releasing peptide hexarelin with somatostatin.

Massoud AF, Hindmarsh PC, Brook CG.

Clin Endocrinol (Oxf). 1997 Nov;47(5):537-47.

PMID:
9425393
13.

The effect of an opiate antagonist on the hormonal changes induced by hexarelin.

Korbonits M, Trainer PJ, Besser GM.

Clin Endocrinol (Oxf). 1995 Sep;43(3):365-71.

PMID:
7586608
14.

Hexarelin decreases slow-wave sleep and stimulates the secretion of GH, ACTH, cortisol and prolactin during sleep in healthy volunteers.

Frieboes RM, Antonijevic IA, Held K, Murck H, Pollmächer T, Uhr M, Steiger A.

Psychoneuroendocrinology. 2004 Aug;29(7):851-60.

PMID:
15177700
15.

Non-acylated ghrelin does not possess the pituitaric and pancreatic endocrine activity of acylated ghrelin in humans.

Broglio F, Benso A, Gottero C, Prodam F, Gauna C, Filtri L, Arvat E, van der Lely AJ, Deghenghi R, Ghigo E.

J Endocrinol Invest. 2003 Mar;26(3):192-6.

PMID:
12809167
16.

Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans.

Broglio F, Prodam F, Gottero C, Destefanis S, Me E, Riganti F, Giordano R, Picu A, Balbo M, Van der Lely AJ, Ghigo E, Arvat E.

Clin Endocrinol (Oxf). 2004 Jun;60(6):699-704.

PMID:
15163333
17.

Hexarelin, a novel GHRP-6 analog, counteracts the inhibitory effect of hydrocortisone on growth hormone secretion in acromegaly.

Giustina A, Bresciani E, Bugari G, Bussi AR, Deghenghi R, Imbimbo B, Giustina G.

Endocr Res. 1995 Aug;21(3):569-82.

PMID:
7588427
18.

Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor.

Muccioli G, Pons N, Ghè C, Catapano F, Granata R, Ghigo E.

Eur J Pharmacol. 2004 Sep 13;498(1-3):27-35.

PMID:
15363972
19.
20.

Natural (ghrelin) and synthetic (hexarelin) GH secretagogues stimulate H9c2 cardiomyocyte cell proliferation.

Pettersson I, Muccioli G, Granata R, Deghenghi R, Ghigo E, Ohlsson C, Isgaard J.

J Endocrinol. 2002 Oct;175(1):201-9.

Supplemental Content

Support Center